A detailed history of Colonial Trust Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Colonial Trust Advisors holds 7,663 shares of MRK stock, worth $762,085. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,663
Previous 3,728 105.55%
Holding current value
$762,085
Previous $461,000 88.72%
% of portfolio
0.08%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $437,375 - $507,496
3,935 Added 105.55%
7,663 $870,000
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $37,387 - $40,153
-302 Reduced 7.49%
3,728 $461,000
Q1 2024

May 13, 2024

SELL
$113.24 - $131.95 $29,442 - $34,307
-260 Reduced 6.06%
4,030 $531,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $128,731 - $140,090
1,285 Added 42.76%
4,290 $467,000
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $59,299 - $65,854
-576 Reduced 16.08%
3,005 $309,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $39,208 - $42,735
-361 Reduced 9.16%
3,581 $413,000
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $100,057 - $111,643
972 Added 32.73%
3,942 $419,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $4,809 - $6,166
55 Added 1.89%
2,970 $329,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $246,404 - $276,808
2,915 New
2,915 $251,000
Q2 2019

Aug 21, 2019

SELL
$69.84 - $81.59 $234,732 - $274,223
-3,361 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $233,858 - $266,728
3,361 New
3,361 $280,000
Q1 2018

May 10, 2018

SELL
$50.96 - $59.23 $335,571 - $390,029
-6,585 Closed
0 $0
Q4 2017

Feb 21, 2018

BUY
$51.62 - $61.64 $339,917 - $405,899
6,585
6,585 $371,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Colonial Trust Advisors Portfolio

Follow Colonial Trust Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.